SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Completed · Phase 2

Conditions studied: Alzheimer's Disease

In brief

The purpose of this trial is to determine the effect of a new drug, SGS742, on memory and cognition in patients with mild to moderate Alzheimer's disease.

Key facts

Study ID

NCT00093951

Run by

Saegis Pharmaceuticals

People needed

280

Starts

2004-04-01

Expected to finish

2007-09-01

Last updated by the study team

2009-12-11

Who can join

Age: 55 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 55 to 90 years of age
• Diagnosed with mild to moderate Alzheimer's disease
• Willing caregiver
• In general good health

You may not qualify if…

• Call 1-877-MY-MEMORY and ask to be referred to a study center located near you for entry criteria information.
• Prohibited Meds:
• Alzheimer's medications (Aricept, Exelon, Remydl, Nemenda)

Where it is running

• Dedicated Clinical Research — Sun City, Arizona, United States
• Northwest NeuroSpecialists, PLLC — Tucson, Arizona, United States
• Clinical Trials Incorporated — Little Rock, Arkansas, United States
• Margolin Brain Institute — Fresno, California, United States
• NervePro Research — Irvine, California, United States
• Center for Neurologic Studies — La Jolla, California, United States
• Neuro Therapeutics, Inc. — Pasadena, California, United States
• Pacific Research Network, Inc. — San Diego, California, United States
• Affiliated Research Institute — San Diego, California, United States
• San Francisco Clinical Research Center — San Francisco, California, United States
• Southern California Clinical Research, Inc. — San Marino, California, United States
• The Mile High Research Center — Denver, Colorado, United States
• Research Center for Clinical Studies, Inc. — Darien, Connecticut, United States
• Study site — Stamford, Connecticut, United States
• Baumel-Eisner Neuromedical Institute, Inc. — Boca Raton, Florida, United States
• Bradenton Neurology, Inc. — Bradenton, Florida, United States
• Brain Matters, Inc. — Delray Beach, Florida, United States
• Baumel-Eisner Neuromedical Institute — Fort Lauderdale, Florida, United States
• Berma Research Group — Hialeah, Florida, United States
• Allied Clinical Trials, The Neurology Group — Miami, Florida, United States
• Tukoi Institute for Clinical Research — Miami, Florida, United States
• Baumel-Eisner Neuromedical Institute — Miami Beach, Florida, United States
• Ocala Neurodiagnostic Center — Ocala, Florida, United States
• Study site — Orange City, Florida, United States
• Study site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.